Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
Alexandria Real Estate Equities
ARE
$9.05B
| $18.3M | ﹤0.01% |
154,200
-1,500
| -1% | -$179K |
|
1902
PUT
Kinsale Capital Group
KNSL
$8.71B
| $18.3M | ﹤0.01% |
39,300
-1,300
| -3% | -$575K |
|
1903
State Street
STT
$53.3B
| $18.3M | ﹤0.01% |
206,803
+41,417
| +25% | +$3.42M |
|
1904
CALL
Doximity
DOCS
$4.57B
| $18.3M | ﹤0.01% |
419,100
+29,000
| +7% | +$967K |
|
1905
PUT
Neurocrine Biosciences
NBIX
$15.8B
| $18.3M | ﹤0.01% |
158,400
+79,200
| +100% | +$10.9M |
|
1906
CALL
Trip.com Group
TCOM
$28.2B
| $18.2M | ﹤0.01% |
306,900
+198,000
| +182% | +$9.16M |
|
1907
Hilton Worldwide
HLT
$73.8B
| $18.2M | ﹤0.01% |
79,072
+15,310
| +24% | +$3.31M |
|
1908
BridgeBio Pharma
BBIO
$15.4B
| $18.2M | ﹤0.01% |
715,157
+38,508
| +6% | +$1.01M |
|
1909
Carrier Global
CARR
$48.4B
| $18.2M | ﹤0.01% |
226,189
+11,327
| +5% | +$789K |
|
1910
Iron Mountain
IRM
$36.6B
| $18.2M | ﹤0.01% |
153,126
+34,862
| +29% | +$3.73M |
|
1911
CALL
EPAM Systems
EPAM
$5.87B
| $18.2M | ﹤0.01% |
91,400
+7,200
| +9% | +$1.44M |
|
1912
PUT
Weibo
WB
$1.73B
| $18.2M | ﹤0.01% |
1,803,400
+592,900
| +49% | +$4.67M |
|
|
SLNO
1913
CALL
DELISTED
Soleno Therapeutics
SLNO
| $18.2M | ﹤0.01% |
359,900
+334,400
| +1,311% | +$16M |
|
1914
CALL
Penumbra
PEN
$12.7B
| $18.2M | ﹤0.01% |
93,500
-26,100
| -22% | -$4.93M |
|
1915
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$758M
| $18.1M | ﹤0.01% |
232,700
+72,575
| +45% | +$5.1M |
|
1916
CALL
Ascendis Pharma A/S
ASND
$16.4B
| $18.1M | ﹤0.01% |
121,300
+41,800
| +53% | +$5.64M |
|
1917
CALL
Oscar Health
OSCR
$9.62B
| $18.1M | ﹤0.01% |
852,300
+75,900
| +10% | +$1.37M |
|
1918
News Corp Class A
NWSA
$16.7B
| $18.1M | ﹤0.01% |
678,766
+83,112
| +14% | +$2.26M |
|
1919
CALL
Cracker Barrel
CBRL
$1.26B
| $18.1M | ﹤0.01% |
398,500
-29,100
| -7% | -$1.2M |
|
|
SKX
1920
PUT
DELISTED
Skechers
SKX
| $18M | ﹤0.01% |
269,400
-166,800
| -38% | -$10.9M |
|
1921
CALL
AdaptHealth
AHCO
$748M
| $18M | ﹤0.01% |
1,602,100
+502,200
| +46% | +$5.34M |
|
1922
CALL
Sociedad Química y Minera de Chile
SQM
$22.7B
| $17.9M | ﹤0.01% |
429,700
+101,900
| +31% | +$3.9M |
|
1923
CALL
Aramark
ARMK
$15.7B
| $17.9M | ﹤0.01% |
462,400
+81,400
| +21% | +$2.87M |
|
1924
PUT
Virgin Galactic
SPCE
$450M
| $17.9M | ﹤0.01% |
2,934,400
-356,300
| -11% | -$2.38M |
|
1925
PUT
Jacobs Solutions
J
$17.7B
| $17.9M | ﹤0.01% |
138,067
+61,539
| +80% | +$7.42M |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.